pI: 7.2715 |
Length (AA): 441 |
MW (Da): 48955 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There is 1 model calculated for this protein. More info on
this model, including the
model itself is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 438 | 2xs1 (A) | 2 | 435 | 44.00 | 0 | 1 | 1.53363 | -0.22 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128537)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G15130 | endosomal targeting BRO1-like domain-containing protein |
Brugia malayi | Bm1_48390 | Programmed cell death 6 interacting protein |
Candida albicans | CaO19.4800 | positive regulator of alkaline-induced genes via proteolysis of RIM101 transcription factor |
Candida albicans | CaO19.12263 | positive regulator of alkaline-induced genes via proteolysis of RIM101 transcription factor |
Caenorhabditis elegans | CELE_R10E12.1 | Protein ALX-1, isoform B |
Dictyostelium discoideum | DDB_G0275451 | ALG-2 interacting protein X |
Drosophila melanogaster | Dmel_CG12876 | ALG-2 interacting protein X |
Echinococcus granulosus | EgrG_000997530 | programmed cell death 6 interacting protein |
Echinococcus granulosus | EgrG_000997550 | programmed cell death 6 interacting protein |
Entamoeba histolytica | EHI_181220 | adhesin 112 (EhADH112) |
Entamoeba histolytica | EHI_165220 | hypothetical protein |
Echinococcus multilocularis | EmuJ_000997530 | programmed cell death 6 interacting protein |
Echinococcus multilocularis | EmuJ_000016600 | programmed cell death 6 interacting protein |
Echinococcus multilocularis | EmuJ_000997550 | programmed cell death 6 interacting protein |
Homo sapiens | ENSG00000170248 | programmed cell death 6 interacting protein |
Leishmania braziliensis | LbrM.27.1770 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_271540.1 | BRO1-like domain/ALIX V-shaped domain binding to HIV, putative |
Leishmania infantum | LinJ.27.1540 | hypothetical protein, conserved |
Leishmania major | LmjF.27.1640 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.27.1640 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_05135 | hypothetical protein |
Loa Loa (eye worm) | LOAG_06002 | alix-SF |
Mus musculus | ENSMUSG00000032504 | programmed cell death 6 interacting protein |
Oryza sativa | 4330097 | Os02g0638400 |
Oryza sativa | 4348999 | Os10g0495300 |
Saccharomyces cerevisiae | YOR275C | Rim20p |
Schistosoma japonicum | Sjp_0089960 | Programmed cell death 6-interacting protein, putative |
Schistosoma japonicum | Sjp_0054960 | Programmed cell death 6-interacting protein, putative |
Schistosoma mansoni | Smp_087620 | programmed cell death protein |
Schmidtea mediterranea | mk4.016571.00 | |
Schmidtea mediterranea | mk4.020314.00 | |
Trypanosoma brucei gambiense | Tbg972.11.2530 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.11.2280 | BRO1-like domain/ALIX V-shaped domain binding to HIV, putative |
Trypanosoma congolense | TcIL3000.11.2040 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.503593.30 | BRO1-like domain/ALIX V-shaped domain binding to HIV, putative |
Trypanosoma cruzi | TcCLB.506127.150 | BRO1-like domain/ALIX V-shaped domain binding to HIV, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.18.0002 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb11.18.0002 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.18.0002 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.18.0002 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.